PLASTEM Trademark

Trademark Overview

On Tuesday, December 12, 2017, a trademark application was filed for PLASTEM with the United States Patent and Trademark Office. The USPTO has given the PLASTEM trademark a serial number of 87717017. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, May 18, 2024. This trademark is owned by GRIFOLS WORLDWIDE OPERATIONS LIMITED. The PLASTEM trademark is filed in the Pharmaceutical Products category with the following description:

Human plasma derived protein supplements containing Albumin, used in mammal cell cultured solutions for research, pharmaceutical and medical purposes
plastem

General Information

Serial Number87717017
Word MarkPLASTEM
Filing DateTuesday, December 12, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, May 18, 2024
Registration Number5593908
Registration DateTuesday, October 30, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 17, 2018

Trademark Statements

Goods and ServicesHuman plasma derived protein supplements containing Albumin, used in mammal cell cultured solutions for research, pharmaceutical and medical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 21, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGRIFOLS WORLDWIDE OPERATIONS LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDublin 22
IE
Party NameGRIFOLS WORLDWIDE OPERATIONS LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin 22
IE
Party NameGRIFOLS WORLDWIDE OPERATIONS LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin 22
IE

Trademark Events

Event DateEvent Description
Monday, January 1, 2018ASSIGNED TO LIE
Friday, December 15, 2017NEW APPLICATION ENTERED
Monday, December 18, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, December 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 8, 2018PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, January 26, 2018ASSIGNED TO EXAMINER
Monday, January 29, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, January 29, 2018LETTER OF SUSPENSION E-MAILED
Monday, January 29, 2018SUSPENSION LETTER WRITTEN
Friday, June 8, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, June 11, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 11, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 12, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 14, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 27, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 17, 2018PUBLISHED FOR OPPOSITION
Tuesday, July 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 26, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 14, 2023TEAS SECTION 8 & 15 RECEIVED
Tuesday, September 11, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 13, 2018TEAS DELETE 1(B) BASIS RECEIVED
Thursday, September 13, 2018NOTICE OF ALLOWANCE CANCELLED
Wednesday, September 26, 20181(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, October 30, 2018REGISTERED-PRINCIPAL REGISTER
Monday, October 30, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Saturday, May 18, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, May 18, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, May 18, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

plastem solutions cultured cell research pharmaceutical purposes medical mammal used derived